Navigation Links
SCOLR Pharma, Inc. First Quarter 2011 Financial Results
Date:5/9/2011

ter ended March 31, 2011 were $184,000, an 11% increase, compared to $166,000 for the same period in 2010. This increase is due to the recognition of $100,000 in revenue attributable to our contract with RedHill Biopharma Ltd. for certain development services in connection with the license by RedHill of our CDT platforms for use in Ondansetron tablet formulations. Off-setting this increase is a $75,000 reduction in royalty revenue from sales of SCOLR nutritional products by Perrigo Company ("Perrigo"). The Company receives royalty payments based on Perrigo's net profits derived from the sales of products subject to the license agreement.  As previously reported, during the fourth quarter of 2010, the Company was informed by Perrigo that some retail accounts will no longer carry certain Perrigo products.  The Company expects revenues from Perrigo to decrease substantially as remaining product inventory is sold through during the first half of 2011. 

For the quarter ended March 31, 2011, the Company's marketing and selling expenses increased 112%, or $66,000 to $125,000 for the three months ended March 31, 2011, compared to $59,000 for the same period in 2010.  

Research and development expenses increased 90%, or $307,000, to $647,000 for the three months ended March 31, 2011, compared to $340,000 for the same period in 2010.  This increase is due primarily to advancement during the first quarter of 2011 of the "actual use" study required to be completed in advance of regulatory submission of our ibuprofen lead product, research and development work for RedHill, and formulation work related to nutritional products.

Net loss increased 16%, or $171,000 to $1,222,000 for the three months ended March 31, 2011, compared to $1,051,000 for the same period in 2010. The increase in net loss reflects higher research and development expenses primarily associated with clinical supplies and preparation activities related to the ibupr
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
4. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
5. SCOLR Pharma, Inc. Licenses Dietary Supplements
6. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
7. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
8. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
9. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
10. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
11. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 RenovoRx ( ... 2013 TiE50 "Top Startup" Award at TiEcon 2013, the ... strong management team and quality of entrepreneurial ideas. RenovoRx ... the Santa Clara Convention Center. ... influential list of the most enterprising startup companies across ...
(Date:5/21/2013)... , May 21, 2013 On ... impressive new product developments at the Special Libraries Association PHTD ... of unerring focus on product literature databases and workflow solutions ... the occasion," said founding director Nigel Johnson ... of benefit to our clients and what better forum to ...
(Date:5/21/2013)... N.J. , May 21, 2013 /PRNewswire-iReach/ -- The ... in NJ has attracted the greatest number of ... its President, Mark Alexay .  ... plans to attend this year.  The show,s still 4 ... different companies.  This is a big surprise and ...
Breaking Medicine Technology:RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2
... 2012 Top leaders representing America,s advanced medical ... public policy issues affecting job creation and medical innovation and ... billion medical device tax set to begin in January 2013. ... Renacci (R-Ohio) joined Walter M Rosebrough, president and CEO of ...
... 2012 /PRNewswire-Asia/ -- Neusoft Medical Systems Co., Ltd. ... today announced its introduction of NeuViz 64 multi-slice ... developed independently by Neusoft Medical, debuted at the ... 2012. Currently pending approval from the ...
Cached Medicine Technology:AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 3Neusoft Medical Launches NeuViz 64 Multi-slice CT Scanner at CMEF Spring 2012 2
(Date:5/21/2013)... AURORA, Colo. (May 21, 2013) Research into genetic ... the University of Colorado School of Medicine may lead ... to a paper published online by JAMA . ... helps predict survival in some cases of pulmonary fibrosis, ... three years. As a result of the study, researchers ...
(Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
(Date:5/21/2013)... 2013 The nation’s first trial involving ... nearing its conclusion in Washington state court, Bernstein Liebhard ... yesterday, an attorney for the Plaintiffs compared Intuitive Surgical ... tie sales and services for its customers. ... control of surgeons, to keep control of hospitals and ...
(Date:5/21/2013)... City, Utah (PRWEB) May 21, 2013 ... HRA, HSA and FSA accounts. Zane Benefits, ... sponsored health benefits, is the leader in defined ... health reimbursement arrangements . , According to Zane Benefits’ ... health reform) was signed into law in 2010 and ...
(Date:5/21/2013)... Washington, DC (PRWEB) May 21, 2013 ... Solid Benefits Guidance (SBG) will identify which strategies can ... while ensuring high-quality care to the members who are ... Atlantic Information Services, Inc., “How to Manage Specialty ... , Specialty pharmaceuticals are now the main driver for ...
Breaking Medicine News(10 mins):Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2
... Analytics provides a roadmap to the,decision makers and ... CHICAGO, Jan. 7 Understanding the Canadian,health information ... data available in the just-released HIMSS Analytics Canadian,Database. ... collection,efforts on hospitals and health systems throughout the ...
... are circumcised can enjoy the same levels of sexual satisfaction ... study of nearly 4,500 males published in the January issue ... trial, carried out by researchers from Uganda and the USA, ... which is now recommended as an efficient way to reduce ...
... reduces foetus size during pregnancy, according to a new ... senior research fellow Dr Adrian Barnett said the study ... scans in Brisbane to air pollution levels within a ... that mothers with a higher exposure to air pollution ...
... than their white counterparts to receive therapy for various ... in treatment, according to a study by researchers at ... online issue of the journal Cancer. , Prior research ... 1990s. Cary P. Gross, M.D., associate professor of medicine ...
... show a trend, but reasons aren,t clear , , MONDAY, Jan. ... at higher risk of prostate cancer compared to those who ... large-scale study looked at all men born in Denmark between ... 17 percent lower incidence of prostate cancer than fathers did. ...
... Insulet,s OmniPod(R) Personal Diabetes Manager to Integrate DexCom ... Continuous Glucose Monitoring Technology, ... Insulet,Corporation (Nasdaq: PODD ), the leader in wearable ... DexCom, Inc. (Nasdaq:,DXCM), a leading provider of continuous glucose ...
Cached Medicine News:Health News:Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM) 2Health News:Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM) 3Health News:Circumcision doesn't reduce sexual satisfaction and performance, says study of 4,500 men 2Health News:Pollution shrinks fetus size: Brisbane study finds 2Health News:Despite efforts, significant racial disparities in cancer therapy still exist 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 3Health News:Insulet Corporation and DexCom Announce Development Agreement 2Health News:Insulet Corporation and DexCom Announce Development Agreement 3Health News:Insulet Corporation and DexCom Announce Development Agreement 4Health News:Insulet Corporation and DexCom Announce Development Agreement 5Health News:Insulet Corporation and DexCom Announce Development Agreement 6
... is the cycler that revolutionized thermal cycling. ... consistent results, experiment-to-experiment and block-to-block. This rugged ... it's a platform for new features and ... thermal cycler chassis, does not include the ...
... The Gene Cycler unit is an inexpensive personal ... for the PCR process. Lightweight, with a small ... almost anywhere, including the researcher's desk. , The ... researchers who do not have access to a ...
Contains: Card, cabling and instructions to remotely access a RoboCycler® instrument from a PC or Macintosh® computer...
... Ideal for day-to-day temperature ... of 0.1C ,30% reduction ... Peltier or coolant-based cyclers ... temperature ramping ,Options for ...
Medicine Products: